...
首页> 外文期刊>European Journal of Haematology >Free iron catalyzes oxidative damage to hematopoietic cells/mesenchymal stem cells in vitro and suppresses hematopoiesis in iron overload patients
【24h】

Free iron catalyzes oxidative damage to hematopoietic cells/mesenchymal stem cells in vitro and suppresses hematopoiesis in iron overload patients

机译:游离铁在体外催化对造血细胞/间充质干细胞的氧化损伤,并抑制铁超负荷患者的造血作用

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: Transfusional iron overload is of major concern in hematological disease. Iron-overload-related dyserythropoiesis and reactive oxygen species (ROS)-related damage to hematopoietic stem cell (HSC) function are major setbacks in treatment for such disorders. We therefore aim to investigate the effect of iron overload on hematopoiesis in the patients and explore the role of ROS in iron-induced oxidative damage in hematopoietic cells and microenvironment in vitro. Patients and methods: The hematopoietic colony-forming capacity and ROS level of bone marrow cells were tested before and after iron chelation therapy. In vitro, we first established an iron overload model of bone marrow mononuclear cells (BMMNC) and umbilical cord-derived mesenchymal stem cells (UC-MSC). ROS level, cell cycle, and apoptosis were measured by FACS. Function of cells was individually studied by Colony-forming cell (CFC) assay and co-culture system. Finally, ROS-related signaling pathway was also detected by Western blot. Results: After administering deferoxamine (DFO), reduced blood transfusion, increased neutrophil, increased platelet, and improved pancytopenia were observed in 76.9%, 46.2%, 26.9%, and 15.4% of the patients, respectively. Furthermore, the colony-forming capacity of BMMNC from iron overload patient was deficient, and ROS level was higher, which were partially recovered following iron chelation therapy. In vitro, exposure of BMMNC to ferric ammonium citrate (FAC) for 24 h decreased the ratio of CD34+ cell from 0.91 ± 0.12% to 0.39 ± 0.07%. Excessive iron could also induce apoptosis, arrest cell cycle, and decrease function of BMMNC and UC-MSC, which was accompanied by increased ROS level and stimulated p38MAPK, p53 signaling pathway. More importantly, N-acetyl-L-cysteine (NAC) or DFO could partially attenuate cell injury and inhibit the signaling pathway induced by excessive iron. Conclusions: Our study shows that iron overload injures the hematopoiesis by damaging hematopoietic cell and hematopoietic microenvironment, which is mediated by ROS-related signaling proteins.
机译:目的:输血铁超载是血液系统疾病的主要关注点。与铁超负荷相关的异常性红细胞生成和与活性氧(ROS)相关的造血干细胞(HSC)功能受损是治疗此类疾病的主要挫折。因此,我们旨在研究铁超负荷对患者造血功能的影响,并探讨ROS在铁诱导的造血细胞和微环境氧化损伤中的作用。患者和方法:在铁螯合治疗之前和之后检测造血集落形成能力和骨髓细胞的ROS水平。在体外,我们首先建立了骨髓单核细胞(BMMNC)和脐带衍生的间充质干细胞(UC-MSC)的铁超负荷模型。通过FACS测量ROS水平,细胞周期和凋亡。通过集落形成细胞(CFC)测定法和共培养系统分别研究细胞的功能。最后,还通过蛋白质印迹检测了ROS相关的信号通路。结果:服用去铁胺(DFO)后,分别有76.9%,46.2%,26.9%和15.4%的患者观察到输血减少,中性粒细胞增加,血小板增加和全血细胞减少症。此外,铁超负荷患者的BMMNC菌落形成能力不足,ROS水平较高,铁螯合治疗后可部分恢复。在体外,将BMMNC暴露于柠檬酸铁铵(FAC)24小时将CD34 +细胞的比例从0.91±0.12%降至0.39±0.07%。过量的铁还可能诱导细胞凋亡,阻滞细胞周期并降低BMMNC和UC-MSC的功能,并伴有ROS水平升高和刺激的p38MAPK,p53信号通路。更重要的是,N-乙酰基-L-半胱氨酸(NAC)或DFO可以部分减轻细胞损伤并抑制过量铁诱导的信号传导途径。结论:我们的研究表明,铁超载通过破坏由ROS相关信号蛋白介导的造血细胞和造血微环境而损害造血作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号